Literature DB >> 23832847

Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors.

Irene Thomassen1, Yvette R van Gestel, Bert van Ramshorst, Misha D Luyer, Koop Bosscha, Simon W Nienhuijs, Valery E Lemmens, Ignace H de Hingh.   

Abstract

Peritoneal carcinomatosis (PC) is an important cause of morbidity and mortality among patients with gastric cancer. The aim of the current study was to provide reliable population-based data on the incidence, risk factors and prognosis of PC of gastric origin. All patients diagnosed with gastric cancer in the area of the Eindhoven Cancer Registry between 1995 and 2011 were included. Incidence and survival were computed and risk factors for peritoneal carcinomatosis were determined using multivariate logistic regression analysis. In total, 5,220 patients were diagnosed with gastric cancer, of whom 2,029 (39%) presented with metastatic disease. PC was present in 706 patients (14%) of whom 491 patients (9%) had PC as the only metastatic site. Younger age (<60 years), female gender, advanced T- and N-stage, primary tumor of signet ring cells or linitis plastica and primary tumors covering multiple anatomical locations of the stomach were all associated with a higher odds ratios of developing PC. Median survival of patients without metastases was 14 months, but only 4 months for patients with PC. PC is a frequent condition in patients presenting with gastric cancer, especially in younger patients with advanced tumor stages. Given the detrimental influence of PC on survival, efforts should be undertaken to further explore the promising results that were obtained in preventing or treating this condition with multimodality strategies.
Copyright © 2013 UICC.

Entities:  

Keywords:  gastric cancer; incidence; metastasis; peritoneal carcinomatosis; prognosis; treatment

Mesh:

Year:  2013        PMID: 23832847     DOI: 10.1002/ijc.28373

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  155 in total

Review 1.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.

Authors:  Ramakrishnan Ayloor Seshadri; Olivier Glehen
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.

Authors:  Haifang Wang; Wenxiang Chen; Peng Yang; Jun Zhou; Kaiyuan Wang; Qingchun Tao
Journal:  Cancer Biol Ther       Date:  2018-11-07       Impact factor: 4.742

3.  Long noncoding RNA aberrant expression profiles after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of AGC ascertained by microarray analysis.

Authors:  Xiaoqi Zeng; Huijuan Shi; Jiping Wang; Shuzhong Cui; Hongsheng Tang; Xiangliang Zhang
Journal:  Tumour Biol       Date:  2015-02-05

Review 4.  A critical analysis of the cytoreductive surgery with hyperthermic intraperitoneal chemotherapy combo in the clinical management of advanced gastric cancer: an effective multimodality approach with scope for improvement.

Authors:  Maneesh K Beeharry; Wen-Tao Liu; Xue-Xin Yao; Min Yan; Zheng-Gang Zhu
Journal:  Transl Gastroenterol Hepatol       Date:  2016-10-20

5.  Effect of expressions of tumor necrosis factor α and interleukin 1B on peritoneal metastasis of gastric cancer.

Authors:  Lin Guo; Jin-Lei Ou; Tong Zhang; Liang Ma; Long-Fei Qu
Journal:  Tumour Biol       Date:  2015-06-12

6.  Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline.

Authors:  R C Auer; D Sivajohanathan; J Biagi; J Conner; E Kennedy; T May
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

Review 7.  Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview.

Authors:  Miguel Alberto; Andreas Brandl; Pankaj Kumar Garg; Safak Gül-Klein; Mathias Dahlmann; Ulrike Stein; Beate Rau
Journal:  Clin Exp Metastasis       Date:  2019-02-04       Impact factor: 5.150

8.  Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.

Authors:  S Bremholm Ellebæk; M Graversen; S Detlefsen; L Lundell; C W Fristrup; P Pfeiffer; M B Mortensen
Journal:  Clin Exp Metastasis       Date:  2020-01-30       Impact factor: 5.150

9.  Hypoxic gastric cancer-derived exosomes promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1α positive feedback loop.

Authors:  Xiang Xia; Shuchang Wang; Bo Ni; Shunpeng Xing; Hui Cao; Zizhen Zhang; Fengrong Yu; Enhao Zhao; Gang Zhao
Journal:  Oncogene       Date:  2020-08-21       Impact factor: 9.867

10.  The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.

Authors:  Ramakrishnan Ayloor Seshadri; Olivier Glehen
Journal:  Indian J Surg Oncol       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.